Identifying Better Outcome Measures to Improve Treatment of Agitation in Dementia: A Report from the EU/US/CTAD Task Force

For the second time in the past 3 years, the EU-US CTAD Task Force addressed challenges related to designing clinical trials for agitation in dementia, which is one of the most disruptive aspects of the condition for both patients and caregivers. Six recommendations emerged from the Task Force meeti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Prev Alzheimers Dis
Main Authors: Sano, M., Soto, M., Carrillo, M., Cummings, J., Hendrix, S., Mintzer, J., Porsteinsson, A., Rosenberg, P., Schneider, L., Touchon, J., Aisen, P., Vellas, B., Lyketsos, C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6441964/
https://ncbi.nlm.nih.gov/pubmed/29616702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14283/jjpad.2018.15
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados